Ipravent 20 mcg Inhaler 200 mdi is used to treat asthma and chronic obstructive pulmonary disease (COPD). Asthma is a condition in which airways narrow and swell, resulting in difficulty breathing, coughing, and wheezing (a whistling sound). COPD is a chronic (long-term) condition caused by a group of lung diseases, such as emphysema (a condition in which the air sacs of the lungs are damaged) and chronic bronchitis (inflammation of tubes (bronchi) that carry air to and from the lungs).

Ipravent 20 mcg Inhaler 200 mdi contains ‘Ipratropium bromide’, which is an anticholinergic. It is used to treat symptoms associated with chronic lung conditions and reduce the risk of frequent asthma attacks. It acts as a bronchodilator and works by dilating the muscles in the airway. It also reduces mucus (phlegm) production. This effect helps to improve lung function and reduce breathing difficulty. It is a short-acting drug.

Ipravent 20 mcg Inhaler 200 mdi is available only for inhalation. Use this medicine as prescribed by your doctor. The common side-effects of Ipravent 20 mcg Inhaler 200 mdi are headache, dizziness, epistaxis (nosebleed), nausea, nasal dryness, nasal irritation, stomach upset, and cough, and throat irritation after inhalation. Most of these side effects resolve themselves without requiring medical attention. However, if the side effects persist or worsen, seek medical help immediately.

Do not take Ipravent 20 mcg Inhaler 200 mdi if you are allergic to ‘ipratropium bromide’ or any other ingredients present in it. Before taking Ipravent 20 mcg Inhaler 200 mdi, inform your doctor if you have a history of glaucoma (an eye condition), urinary retention and an enlarged prostate gland. Inform your doctor if you are using any prescription, non-prescription or nutritional supplements; also, inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding.

Ipravent 20 mcg Inhaler 200 mdi contains ‘ipratropium bromide’, which is an ‘anticholinergic’ drug. It is a widely used bronchodilator. It can effectively reduce symptoms of asthma, chronic obstructive pulmonary disease(COPD) and other lung conditions. It can also decrease the risk of recurrent asthma episodes. It helps to improve lung function. It relaxes the muscles along the airway passage, easing the breathing difficulty. It reduces phlegm production, improving cough symptoms. Besides, it has a quick onset of action.

• Breathlessness
• Headache, dizziness
• Nausea, stomach upset 
• Epistaxis (nosebleed), nasal dryness, nasal irritation and cough
• Throat irritation after inhalation

Do not take Ipravent 20 mcg Inhaler 200 mdi if you are allergic to ‘ipratropium bromide’ or any ingredients present in it. This medicine should be used with caution in patients with glaucoma (increased inside pressure of the eye) and urinary retention. The inhalation should be used carefully. Ensure the medicine does not reach the eye as it may result in eye problems such as mydriasis (dilation of the pupil), increased pressure inside the eye, and angle-closure glaucoma (a condition caused by blocked drainage canals in the eye), eye pain, and visual halos. If you develop paradoxical bronchospasm (sudden narrowing of bronchi muscles leading to obstructed breathing), you should discontinue treatment immediately and consult a doctor. This medicine should be used with caution in pregnant and breastfeeding women. 

Drug-drug interactions: Ipravent 20 mcg Inhaler 200 mdi may interact with other anticholinergics used to treat COPD (tiotropium), irritable bowel syndrome (mebeverine), urinary incontinence (oxybutynin and solifenacin), or cough (e.g. dextromethorphan). It may also interact with other drugs that treat lung diseases (salbutamol, theophylline, and aminophylline).

Drug-food interactions: No interactions found.

Drug-disease interactions: Ipravent 20 mcg Inhaler 200 mdi should be used with caution in patients with glaucoma, enlarged prostate gland, cystic fibrosis (an inherited disorder that damages lungs and gut), and urinary retention (difficulty passing urine).

• TIOTROPIUM
• MEBEVERINE
• OXYBUTYNIN
• SOLIFENACIN
• DEXTROMETHORPHAN
• THEOPHYLLINE
• AMINOPHYLLINE

• Know your triggers like allergens, such as pollen, dust, and food items that make your asthma severe.
• Quit smoking and avoid passive smoking. Smoking also reduces the effectiveness of the medicine.
• Eat a healthy diet and exercise regularly to strengthen your breathing muscles and boost your immune system.
• Learning breathing exercises will help you move more air in and out of your lungs.

• If you are taking albuterol and ipratropium in your eyes, there can be a chance that he/she may develop narrow-angle glaucoma. So, if you have narrow-angle glaucoma, your condition may worsen. 
• Take the first dose under medical supervision as it may cause wheezing or tightening of the airways (bronchospasm) immediately after use.
• Monitor your blood potassium level regularly while taking this medication.

Asthma: It is a chronic (long-term) condition in which the airways become swollen and narrowed due to inflammation. It also results in increased production of mucus (thick fluid secreted by respiratory tissues) in the airways. Symptoms include breathing difficulty, coughing, and wheezing (a whistling sound).

Chronic obstructive pulmonary disease (COPD): This is chronic inflammation that occurs due to a group of conditions, such as emphysema, chronic bronchitis, and refractory or recurrent asthma. Emphysema is a condition in which alveoli (air sacs) are damaged, leading to shortness of breath. Chronic bronchitis is a condition in which the bronchus (passage of the airway that conducts air) becomes inflamed, leading to increased sputum production.